Key result
Receiving 3 or more critical care pharmacist medication interventions during an ICU stay was associated with a significantly reduced risk of hospital mortality (ATE -0.04) compared to receiving fewer than 3 interventions.
Why the study?
Medication management in the ICU is linked to treatment success and adverse drug events, but the effect of comprehensive medication management on mortality in critically ill patients required exploration.
Does higher exposure to comprehensive medication management by critical care pharmacists reduce hospital mortality in critically ill adult ICU patients?
Cohort (n=10,441)
No
Does higher exposure to comprehensive medication management by critical care pharmacists reduce hospital mortality in critically ill adult ICU patients?
Mean Difference: -0.04 (95% CI -0.06–-0.03)
p-value: p=<0.01
Higher levels of critical care pharmacist-delivered comprehensive medication management are associated with reduced hospital mortality and shorter ICU length of stay in critically ill patients.
Background Medication management in the intensive care unit (ICU) is causally linked to both treatment success and potential adverse drug events (ADEs), often associated with deleterious consequences. Patients with higher severity of illness tend to require more management. The purpose of this evaluation was to explore the effect of comprehensive medication management (CMM) on mortality in critically ill patients. Methods In this retrospective cohort study of adult ICU patients, CMM was measured by critical care pharmacist (CCP) medication interventions. Propensity score matching was performed to generate a balanced 1:1 matched cohort, and logistic regression was applied for estimating propensity scores. The primary outcome was the odds of hospital mortality. Hospital and ICU length of stay were also assessed. Results In a cohort of 10,441 ICU patients, the unadjusted mortality rate was 11% with a mean APACHE II score of 9.54 ± 4.18 and Medication Regimen Complexity-Intensive Care Unit (MRC-ICU) score of 5.78 ± 4.09. Compared with CCP interventions less than 3, more CCP interventions was associated with a significantly reduced risk of mortality (estimate -0.04, 95% confidence interval -0.06 - -0.03, p < 0.01) and shorter length of ICU stay (estimate -2.77, 95% CI -2.98 - - 2.56, p < 0.01). Conclusions The degree by which CCPs deliver CMM in the ICU is directly associated with reduced hospital mortality independent of patient characteristics and medication regimen complexity.
No takes yet. Share an insight, caveat, or question.
Sikora et al. (2024) conducted a cohort in Critical illness (n=10,441). ≥3 critical care pharmacist medication interventions vs. <3 critical care pharmacist medication interventions was evaluated on Hospital mortality (ATE -0.04, 95% CI -0.06 to -0.03, p=<0.01). Receiving 3 or more critical care pharmacist medication interventions during an ICU stay was associated with a significantly reduced risk of hospital mortality (ATE -0.04) compared to receiving fewer than 3 interventions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: